Transcatheter interventions for valvular heart diseases in liver cirrhosis patients-Reference-Cited by-同舟云学术

Transcatheter interventions for valvular heart diseases in liver cirrhosis patients

Published:2021-12 Issue: Volume: Page:
ISSN:1050-1738
Container-title:Trends in Cardiovascular Medicine
language:en
Short-container-title:Trends in Cardiovascular Medicine

Author:

Ahmed Taha,Misumida Naoki,Grigorian Alla,Tarantini Giuseppe,Messerli Adrian W.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference77 articles.

1. EASL HEPAHEALTH steering committee. burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies;Pimpin;J Hepatol,2018

2. The epidemiology of cirrhosis in the United States: a population-based study;Scaglione;J Clin Gastroenterol,2015

3. Wolf DC. What are the mortality rates for cirrhosis in the US? Medscape [Accessed 8/1/2021]. https://www.medscape.com/answers/185856-109599/what-are-the-mortality-rates-for-cirrhosis-in-the-us

4. The global impact of hepatic fibrosis and end-stage liver disease;Lim;Clin Liver Dis,2008

5. AASLD practice guidelines: evaluation of the patient for liver transplantation;Murray;Hepatology,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease assessment and management in liver transplantation;European Heart Journal;2024-08-17

2. Management of the liver transplant candidate with high cardiac risk: Multidisciplinary best practices and recommendations;Liver Transplantation;2024-05-13

3. Cardiac evaluation of the liver transplant candidate;Current Opinion in Organ Transplantation;2023-11-24

4. Impact of TAVR on patients with severe aortic stenosis and liver cirrhosis;American Journal of Physiology-Heart and Circulatory Physiology;2023-09-01

5. Double Trouble: The Challenge of Neuroprotection in Patients with Liver Cirrhosis and Atrial Fibrillation;American Journal of Cardiovascular Drugs;2023-08-28